Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults
- 1 June 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 175 (6), 631-632
- https://doi.org/10.1001/jamapediatrics.2020.6150
Abstract
Children and young adults with steroid-dependent nephrotic syndrome (SDNS) are exposed to the toxic effects of both steroids and common steroid-sparing agents, such as calcineurin inhibitors, reporting an increased risk of kidney failure.1 Alternative low-toxicity, long-acting therapies are needed to treat SDNS.1 Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.This publication has 7 references indexed in Scilit:
- Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled studyPediatric Nephrology, 2020
- Faculty Opinions recommendation of Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.Published by H1 Connect ,2018
- Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trialKidney International, 2018
- Rituximab in Children with Steroid-Dependent Nephrotic SyndromeJournal of the American Society of Nephrology, 2015
- Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic SyndromeJournal of the American Society of Nephrology, 2013
- Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directionsPediatric Nephrology, 2005
- Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndromePediatric Nephrology, 2005